Olga Brawman‐Mintzer

2.9k total citations
55 papers, 1.6k citations indexed

About

Olga Brawman‐Mintzer is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Olga Brawman‐Mintzer has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Experimental and Cognitive Psychology, 20 papers in Clinical Psychology and 17 papers in Psychiatry and Mental health. Recurrent topics in Olga Brawman‐Mintzer's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (23 papers), Child and Adolescent Psychosocial and Emotional Development (13 papers) and Treatment of Major Depression (11 papers). Olga Brawman‐Mintzer is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (23 papers), Child and Adolescent Psychosocial and Emotional Development (13 papers) and Treatment of Major Depression (11 papers). Olga Brawman‐Mintzer collaborates with scholars based in United States, Canada and Sweden. Olga Brawman‐Mintzer's co-authors include Jacobo Mintzer, R. Bruce Lydiard, R. Bruce Lydiard, Naresh P. Emmanuel, Kimberly A. Yonkers, Rebecca G. Knapp, Moira A. Rynn, Paul J. Nietert, James C. Ballenger and Naresh P. Emmanuel and has published in prestigious journals such as American Journal of Psychiatry, Journal of Consulting and Clinical Psychology and Biological Psychiatry.

In The Last Decade

Olga Brawman‐Mintzer

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Brawman‐Mintzer United States 25 809 665 444 281 227 55 1.6k
Irene M. van Vliet Netherlands 21 650 0.8× 734 1.1× 314 0.7× 236 0.8× 252 1.1× 67 1.6k
Jean‐Pierre Lépine France 21 625 0.8× 426 0.6× 410 0.9× 311 1.1× 141 0.6× 56 1.6k
Amy Farabaugh United States 24 706 0.9× 664 1.0× 443 1.0× 519 1.8× 360 1.6× 63 2.2k
Jennifer H. Martinez United States 19 629 0.8× 444 0.7× 479 1.1× 324 1.2× 222 1.0× 40 1.6k
Alessandro Carano Italy 29 899 1.1× 368 0.6× 988 2.2× 275 1.0× 167 0.7× 62 2.1k
Stéphane Richard‐Devantoy Canada 26 1.2k 1.5× 530 0.8× 732 1.6× 399 1.4× 183 0.8× 98 2.3k
Pratap Chokka Canada 19 861 1.1× 764 1.1× 903 2.0× 416 1.5× 207 0.9× 47 2.4k
J Guelfi France 21 675 0.8× 394 0.6× 710 1.6× 361 1.3× 135 0.6× 62 1.6k
Kevin Kjernisted Canada 15 1.3k 1.7× 893 1.3× 333 0.8× 169 0.6× 214 0.9× 18 2.0k
Tineke van Veen Netherlands 25 637 0.8× 474 0.7× 330 0.7× 210 0.7× 281 1.2× 47 2.2k

Countries citing papers authored by Olga Brawman‐Mintzer

Since Specialization
Citations

This map shows the geographic impact of Olga Brawman‐Mintzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Brawman‐Mintzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Brawman‐Mintzer more than expected).

Fields of papers citing papers by Olga Brawman‐Mintzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Brawman‐Mintzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Brawman‐Mintzer. The network helps show where Olga Brawman‐Mintzer may publish in the future.

Co-authorship network of co-authors of Olga Brawman‐Mintzer

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Brawman‐Mintzer. A scholar is included among the top collaborators of Olga Brawman‐Mintzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Brawman‐Mintzer. Olga Brawman‐Mintzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brawman‐Mintzer, Olga, et al.. (2025). Neuroinflammation: A Driving Force in the Onset and Progression of Alzheimer’s Disease. Journal of Clinical Medicine. 14(2). 331–331. 3 indexed citations
2.
Perin, Jamie, Alden L. Gross, David Shade, et al.. (2024). Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial). International Journal of Geriatric Psychiatry. 39(6). e6108–e6108. 1 indexed citations
3.
Perin, Jamie, Nathan Herrmann, Olga Brawman‐Mintzer, et al.. (2023). Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(3). e12403–e12403. 1 indexed citations
4.
Lanctôt, Krista L., Clara Chen, Alex Kiss, et al.. (2023). Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). International Psychogeriatrics. 35(11). 664–672. 1 indexed citations
5.
Lanctôt, Krista L., Shankar Tumati, Jamie Perin, et al.. (2023). Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial. American Journal of Geriatric Psychiatry. 31(12). 1077–1087. 1 indexed citations
6.
Dyck, Christopher H. van, Amy F.T. Arnsten, Prasad R. Padala, et al.. (2020). Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. American Journal of Geriatric Psychiatry. 29(1). 51–62. 28 indexed citations
7.
Scherer, Roberta W., Lea T. Drye, Jacobo Mintzer, et al.. (2018). The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 19(1). 46–46. 30 indexed citations
8.
Pauls, Qi, et al.. (2016). Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Digestive Diseases and Sciences. 61(9). 2704–2709. 13 indexed citations
9.
Brawman‐Mintzer, Olga, Valerie Durkalski, Qi Wu, et al.. (2014). Psychosocial Characteristics and Pain Burden of Patients With Suspected Sphincter of Oddi Dysfunction in the EPISOD Multicenter Trial. The American Journal of Gastroenterology. 109(3). 436–442. 20 indexed citations
10.
Cotton, Peter B., Valerie Durkalski, Olga Brawman‐Mintzer, et al.. (2010). Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointestinal Endoscopy. 72(5). 986–991. 10 indexed citations
11.
Stein, Murray B., Lakshmi N. Ravindran, Naomi M. Simon, et al.. (2009). Levetiracetam in Generalized Social Anxiety Disorder. The Journal of Clinical Psychiatry. 71(5). 627–631. 30 indexed citations
12.
Brawman‐Mintzer, Olga, Rebecca G. Knapp, Moira A. Rynn, Rickey E. Carter, & Karl Rickels. (2006). Sertraline Treatment for Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 67(6). 874–881. 46 indexed citations
13.
Brawman‐Mintzer, Olga, et al.. (2005). Patients with Generalized Anxiety Disorder and a History of Trauma: Somatic Symptom Endorsement. Journal of Psychiatric Practice. 11(3). 212–215. 12 indexed citations
14.
Brawman‐Mintzer, Olga, Rebecca G. Knapp, & Paul J. Nietert. (2005). Adjunctive Risperidone in Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 66(10). 1321–1325. 84 indexed citations
15.
Rynn, Moira A. & Olga Brawman‐Mintzer. (2004). Generalized Anxiety Disorder: Acute and Chronic Treatment. CNS Spectrums. 9(10). 716–723. 52 indexed citations
16.
Brawman‐Mintzer, Olga & Kimberly A. Yonkers. (2004). New Trends in the Treatment of Anxiety Disorders. CNS Spectrums. 9(S7). 19–27. 11 indexed citations
17.
Yonkers, Kimberly A. & Olga Brawman‐Mintzer. (2002). The Pharmacologic Treatment of Depression. The Journal of Clinical Psychiatry. 63(7). 610–615. 39 indexed citations
18.
Brawman‐Mintzer, Olga. (2001). Pharmacologic Treatment of Generalized Anxiety Disorder. Psychiatric Clinics of North America. 24(1). 119–137. 26 indexed citations
19.
Emmanuel, Naresh P., Olga Brawman‐Mintzer, W. Alexander Morton, et al.. (2000). Bupropion-SR in treatment of social phobia. Depression and Anxiety. 12(2). 111–113. 24 indexed citations
20.
Brawman‐Mintzer, Olga & R. Bruce Lydiard. (1996). Generalized anxiety disorder: issues in epidemiology.. PubMed. 57 Suppl 7. 3–8. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene M. van Vliet Breakdown of academic impact, for papers by Jean‐Pierre Lépine Breakdown of academic impact, for papers by Amy Farabaugh Breakdown of academic impact, for papers by Jennifer H. Martinez Breakdown of academic impact, for papers by Alessandro Carano Breakdown of academic impact, for papers by Stéphane Richard‐Devantoy Breakdown of academic impact, for papers by Pratap Chokka Breakdown of academic impact, for papers by J Guelfi Breakdown of academic impact, for papers by Kevin Kjernisted Breakdown of academic impact, for papers by Tineke van Veen
Rankless by CCL
2026